Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes, 423K shows up well before the $500K Research Funding was announced
BioCentric Energy Receives $500,000 Research Funding From Private California Group
Date : 10/14/2009
Do you think the 20 Million Series B were allocated to the new hires ?
If so, how were the other 60 Million spent ?
Is this the first appearance of series B shares ? There's no record of series B in IBOX
Do our Financials have to be audited before we can uplist to OTC BB ?
Letter states Unudited
I was thinking the same thing. Numbers are close
Perhaps with some sort of performance holdback in place for remainder.
Dales statement doesn't jive with their financial statement
Issuance of Capital stock $423,000 to Sept 30
They raised 423K through issuance of stock. Was this a private placement if not retail ?
how many restricted shares between last reporting period and this reporting period?.
Might give your theory a boost
if any of those things happened it should have shown up in their financials
acquiring technology, expertise, or
capital raising.(does show up @ 423K)
Who knows?
But good question. A little more transparency would be helpful
423K / 80MM = .0053 per share
hardly a great deal for 80 million shares
Issuance of Capital stock $423,000 to Sept 30
about 1/10 th of your claim
ace65 Do not believe 80 million @ 6 cents in Sept
Financials reflect activity to Sept 30.
I didn't see 4.8 million banked. Nice try
Probably multiple uses for the money
Lipid License
Hiring
HQ Build out
Pay role
I'd be REAL disappointed if 80 M shares were used ti hire 1 person (Monique Berry )
I wouldn't be disappointed if 80 million shares were used to secure a Lipid Trigger License or Merger deal
es1. If it walks and talks like a duck
its a duck.
PR Pump and Dump Campaign.
Stay in touch with the Transfer Agent from this point forward.
It wasn't MM's dropping the price
It was DF dilution.
I hope he's finished for now.
Should be keeping closer tabs on dilution activity through Transfer Agent.
Been sleeping at the switch.
80 Mlllion Dilution
Share Structure from IBOX:
Authorized = ........750,000,000
Outstanding = ..... 630,505,685
Float = ................... 348,468,221
From Filing :
Outstanding = .......710,505,685
Any bets on Authorized Share increase ? Just 39.5 Million Left in the pot.
1 Billion around the corner ?
Pony truly a revealing find !
Carter said, "Algae can produce 66,000 gallons of oil per acre, per year; we would be able to produce more oil than we could ever use."
Currently BEHL can produce 50 Gal / Day x 365 Days = 18,250 per year
The only way Extreme can produce 66,000 Gal per year, with a 1 acre system, is with the Lipid Trigger
18,250 x 400% = 73,000 Gal
BEHL must have the Lipid trigger in the Bag. Wouldn't you agree ?
Algea to Power on the Farm
Connect the dots to 10 Million $$ BEHLievers
BEHL 1 Acre System (50 gal/ day) x 365 days = 18,250 Gal / year x (400 % Amplified Algea Solution)
= 73,000 Gal per year !!!!!!!! x 4 years ( Jan1,2011 to Dec 31,2014)
= 292,000 Gallons. BEHL will beat the pants off any Corn Farmer out there.
The team that produces
the most finished renewable diesel fuel per acre of land
that the fuel growing and production facility occupies between
January 1, 2011 and December 31, 2014, with a minimum of 3,000
“net-gallons” produced per acre, at a cost of no more than $3/gallon.
SAN JUAN CAPISTRANO, CA, Aug 14, 2009 (MARKETWIRE via COMTEX) -- BioCentric Energy Holdings, Inc. (PINKSHEETS: BEHL) today announced the company's first successful harvest of ALGAE for the production of clean burning Bio-Diesel fuels significantly exceeded expectations yielding almost 30% more ALGAE than originally projected. The crop produced from the company's on site closed loop Photobioreactor is now on a continual harvest cycle and is producing sufficient ALGAE to produce approximately 8 gallons per day of Bio-Diesel fuel which equates to almost 50% of the crop produced from the 1800 square foot test system. In addition to the Diesel product, the harvest produces high protein animal food supplements which do not require any additional processing. The combination of the Bio-Diesel and animal food supplements makes the production a very cost effective system and profitable solution. Using the company's closed loop system, license holders operating a one acre ALGAE farm would be able to produce in excess of 50 gallons of clean burning Bio-Diesel per day along with significant animal supplement nutrients for retail distribution.
It's a license deal with SGT
BEHL, COO Dennis Shen is awaiting confirmation from the company's overseas research team that the company has in fact access to a proven "Lipid Trigger" method of increasing ALGAE growth x 5 using the same closed loop system. This will revolutionize the ALGAE alternative fuel industry for replacing natural crude oil.
The oil companies have been searching for the "Lipid Trigger" for years it now seems that upon confirmation by the company's scientific research team Biocentric in conjunction with it's potential new strategic partner may have the world's solution to alternative fuel Bulk ALGAE production:
See attached link:
http://www.biomassmagazine.com/article.jsp?article_id=3002
http://www.prlog.org/10355536-behl-huge-dd-update-from-behl.html
BMP Can you confirm it's NOT a License Deal with SGT
BMP How reliable is your source ? Has your source been reliable in the past ?
If what you say is true, the 10 million prize belongs to BEHL and this company's SP will move violently up.
They just received a 500K private placement.
Should be more than enough to bridge the 6 million order now in production.
If we don't secure the SGT Lipid Trigger maybe we just pay them a fee to increase our production output. Or maybe we do a joint venture with them on a large production run.
I'm sure it's not the end of the world without the SGT Merger.
Would have been nice, but not necessary for our survival.
Didn't they just receive a 500K private placement to keep the wheels oiled?
Would love to Quiz but I'm not privy to it.
I'm much more comfortable with my investment and very happy I had the opportunity to accumulate 4 times more at these lower levels.
A high risk Pinky with a good chance of success selling for just 2 cents.
Ka Ching. 6 million order in the pipe.
Revenue is coming. Let's drive this baby home !
Thanks Phloyd
The Evidence is the joint venture with RWE is locked.
RWE needs the income as much as BEHL.
They are very motivated to fill this 6 million order.
The opportunity to balance your losses is right now @ .022.
I think Denis has learned his lesson and will be more prudent with PR's going forward. He's got a million things on the go and we are moving forward with a 6 million order. What's to bitch about , stock is up 46%.
You'll have to wait until the end of december before you can get an answer to your question. Perhaps DF saw something he didn't like ( no viable way to service 29 million RWE Debt in the short term and didn't want to put us at risk ) and backed out. Have you noticed our share price since we learned the Merger was off ? Up 46.82% in 5 days !!!! Whoa. I like the way things are settling in without the RWE Merger. I like it a lot !
BEHL - BIOCENTRIC ENERGY HO (OTC)
Date Open High Low Last Change Volume % Change
11/19/09 0.0220 0.0220 0.0210 0.0220 +0.0018 3983773 +8.91%
11/18/09 0.0180 0.0230 0.0180 0.0202 +0.0022 9006000 +12.22%
11/17/09 0.0155 0.0184 0.0155 0.0180 +0.0023 6718000 +14.65%
11/16/09 0.0146 0.0165 0.0146 0.0157 +0.0008 4842300 +5.37%
11/13/09 0.0148 0.0150 0.0138 0.0149 +0.0008 5535200 +5.67%
Thanks for those Prize links Phloyd.
He who has the Lipid Trigger holds the key to the Prize.
bigdaddy Are we a Strong contender for the 10 Million Prize?
Winner must produce 3,000 net gallons of diesel fuel per acre at a cost of no more than $3 per gallon.
We seem to have the price well below $3.00 gallon @ 1.50 / gal and I thought they mentioned they were getting 8 gallons a day out of their system. Was that a number out of their 1800 sq ft test system in SJC ?
If they were getting 8 gallons a day out of their 1800 sq ft SJC test system ( 8 x 365 = 2920 gallons per year ) then we must be a VERY STRONG contender for the 10 million prize.
Would you agree ?
How many gallons can a BEHL 1 acre PBR produce in 1 year?
Does anyone have company specs used in the sale of a PBR ?
There must be something available if they commercialized the system.
behl gates => 4.BEHL is testing and constructing PBR's in California located near a MECCA of algae start ups.
Who are the other Algea start ups near BEHL headquarters? Is this statement still true for new Headquarters in HB ?
Winner must produce 3,000 net gallons of diesel fuel per acre at a cost of no more than $3 per gallon. In theory / in practice , Can BEHL do this Now ?
SAN DIEGO ---- Just as the Ansari X Prize jump-started private space flight, a North County venture capital firm has started a competition to produce commercially viable fuel from algae.
The Algae Fuel Prize, offered by Del Mar-based Prize Capital, was announced at this week's Algae Biomass Summit, a meeting in San Diego of experts in using algae for fuel, food, purifying water and other purposes.
The goal is to offer $10 million, the same amount as the Ansari X Prize, said Lee Stein, Prize Capital's founder.
Stein said the actual amount may change, because the rules and guidelines for the prize aren't final. But the main goal is fixed, he said, which is to add a new source of fuel and not to compete with food crops, as with ethanol made from corn.
"We want to work with third-generation biofuels: Land that cannot be used for food," Stein said. "That was our primary concern."
Stein made the announcement at the close of Wednesday's session of the Algae Biomass Summit, briefly taking the stage to show a video about the prize and explain its goals. A sponsor for the prize will be announced soon, he told the audience.
The Algae Fuel Prize's rules specify that the winner must produce 3,000 net gallons of diesel fuel per acre at a cost of no more than $3 per gallon. The net quantity is obtained by subtracting the gallons of fuel used in producing the algae from the yield. Prize Capital will also work to arrange buyers for the fuel.
More information is available at www.prizecapital.net.
Stein founded Prize Capital in 2006 to promote environmentally friendly technology. The veteran entrepreneur made his mark by starting companies such as First Virtual Holdings, established in 1994 to handle Internet payments. First Virtual was sold in 1999 and its patents are now held by eBay.
Prize Capital's goal is to bring innovation to environmental issues, and the prize is modeled after the Ansari X-Prize, Stein said. That prize was won in 2004 by a team sponsored by Microsoft co-founder Paul Allen and Scaled Composites. The rocket for the spacecraft, SpaceShipOne, was made by Poway-based SpaceDev.
Biofuels have received a sudden influx of investment money and interest since gasoline prices spiked last summer. While algae-based fuels are being made now, they cost much more than traditional fuels.
Investors in San Diego County are bidding to make the region a center of research for making fuel from algae, aided by its coastal location and heavy concentration of biotechnology expertise. The federal government also has sponsored research into algae for biofuels, which the military considers a potentially more secure source of fuel than overseas suppliers.
Algae-derived fuel has the advantage of using water than can't be used for drinking, and doesn't divert from food production, as is the case with ethanol made from corn, Stein said. Also, algae could be farmed around the world, making it a potentially attractive occupation for poor countries aspiring to become richer. These countries will inevitably use more energy as they accrue wealth, he said.
"There's an intersection between the developed world and the developing world," Stein said. "There's 1.2 billion people who are living on a second dollar a day. When they get that second dollar, it's all going to energy or food that requires energy."
Instead of building a few extremely large fuel plants, the people of these developing nations might be able to create their own energy on the spot with algae cultivation in a large number of locations, Stein said.
The Algae Biomass Summit, sponsored by the Algal Biomass Organization, ends Friday. Visit www.algalbiomass.org.
Call staff writer Bradley J. Fikes at 760-739-6641. Read his blogs at bizblogs.nctimes.com.
Anyone know the status of 10 Million Algea Prize ?
http://nctimes.com/business/article_dd739405-be25-55a5-ac5a-9014586c3939.html
Martek sells on an October 2009 consensus P/E of 15.1
I'll take a stab at BEHL Valuation
15M Rev 2010 / 640 M shares
= .023 x 15 PE = 35 cents 2010
25M Rev 2011 / 640M shares
= .039 x 15 PE = 58 cents 2011
Martek Biosciences: Can It Turn Algae into Gold, Or at the Least Oil? 4 comments
October 30, 2009 | about: BP / MATK
Beacon Asset Managers
Follow
126
Followers 17
Following
About this author:
Profile & More Articles
Visit: Beacon Asset Management
Font Size: Print EmailTweetThis
Martek Biosciences Corp. (MATK) is a global leader in the production of docosahexaenoic acid from microalgae and arachidonic acid from fungus, and as such stands to benefit from the combined U.S. demographics of an expected uptick in U.S. births, aging baby boomers and an apparently health-conscious Generation Y.
“Wait a minute! Docosahex-what? Arachid-what? Made from microalgae? Fungus? And, what does this have to do with babies, teenagers and the soon-to-be elderly?”
Docosahexaenoic acid, or DHA as its more commonly referred to, is one of the primary omega-3 fatty acids, the same omega-3s that have become all the rage as a food supplement due to their purported health benefits for the heart, brain, eyes and infant development. Arachidonic acid–ARA–is an omega-6 fatty acid that is considered an “essential fatty acid” crucial for muscle and skeletal repair and growth, and, along with DHA, considered a key component neurological development and maintenance.
The health benefits of omega-3s and in particular DHA emerged in the 1970s with a study of Greenland Eskimos who consumed large amounts of fatty seafoods, but displayed virtually no incidence of heart disease. In 2004, the U.S. Food and Drug Administration (FDA) gave DHA “qualified health claim” status that research is supportive, though not conclusive” that its consumption may “reduce the risk of coronary heart disease.”
Other studies determined that DHA and ARA were crucial in brain, eye, muscle and skeletal development in babies. Meanwhile researchers have also determined that DHA may inhibit plaque development in the brain thought to be responsible for Alzheimer’s disease, and there are indications that DHA may inhibit the growth of some cancers. Research of these health benefits and others with both DHA and ARA are ongoing, with one of the largest being a U.S. National Institutes of Health study to evaluate DHA in Alzheimer’s disease.
A primary source of DHA and other omega-3s is fish oils, and fish oil as an omega-3 and DHA dietary supplement essentially went mainstream in the late 1990s as their apparent health benefits become widely known. Fish receive their DHA intake from algae, and scientists with Martin Marietta (which merged with Lockheed (LMT) in 1995)who were researching the beneficial use of algae in long-term space flight, spun off from their parent company and developed and patented the methods for deriving DHA from algae, and ARA from a fungus.
These scientists formed Martek Biosciences in 1985, brought the company public in 1993, and introduced their first DHA and ARA infant formula in 1995 in Belgium, and received FDA clearance for its use in U.S. infant formulas in 2001.
Martek’s core product application remains DHA and ARA as a supplement in infant formulas. Sales of Martek DHA/ARA for infant formulas have more than doubled since 2003, climbing from less than $150 million in 2003 to $300 million in 2008. The company claims 99 percent penetration of the U.S. market, which it views as a “$170 million to $190 million market opportunity;” and 40 percent penetration of the international market, which it pegs as a $300 million to $325 million market opportunity, with the primary future growth driver being Asia. Martek considers consumer demand for infant formula as “stable despite the weak global economy.”
The company’s secondary product application–DHA supplements and additives for adults–has also seen robust growth, with sales climbing from about $11.5 million in 2006 to an estimated $38 million for 2009. Martek sees growing sales across all segments of this market in the years ahead, and believes there will be increasing consumer awareness about the health benefits of DHA.
The company should see increased future sales based on demographics. Although it already has all but complete penetration of the U.S. market for infant formulas, The number of women entering their key child-bearing years is set to increase by roughly 250,000 per year for the next 10 years as the large cohort of Generation Y replaces the much smaller Generation X. Along with more of them, Gen. Y is commonly believed to be much more health conscious with relation to food than members of Gen. X and the Baby Boom. This should be a boon to Martek’s sales of DHA/ARA supplements to pregnant and nursing mothers, as well as to DHA/ARA supplements for other adults.
And as the large cohort of Baby Boomers age their interest in health supplements will undoubtedly increase. The more evidence they hear supporting DHA’s health claims regarding Alzheimer’s Disease, coronary heart disease and cancer, the more money they will pour into DHA supplements, and the more likely that they will purposely purchase products (currently more than 50 and growing) containing Martek’s patented “life’sDHA.”
While the company would appear to be a two-trick pony, it recently entered into a joint development agreement with BP plc. (BP) Biofuels to produce microbial oils for use in the biofuels industry. The goal of the agreement is to “establish proof of concept for large-scale, cost effective microbial biodiesel production through fermentation.” BP committed $10 million to the initial phase of the collaboration, under which BP will own any new intellectual property developments, with Martek receiving exclusive license for application and commercialization in nutrition, cosmetic and pharmaceutical applications. While this agreement adds nothing to the bottom line in the near, or even mid, term, Martek scientists proved visionary in the past, and certainly have the wherewithal to discover new products and applications through this project.
The share price is well off its all-time high of about $67 hit in early 2005, and down about 70 percent from its 52-week high of $31.60. The share price has declined about 40 percent since early September after recording a 12 percent year-over-year decline in quarterly revenues caused by retail companies de-stocking old inventories of infant formulas. Martek executives projected strong fourth-quarter 2009 and full-year 2010 revenues, on anticipated increasing sales in both infant formula and adult products.
In our opinion, one problem with valuing Martek, is does one value the shares on a food company or a biotech company basis? Being conservative, we believe a company should be valued on its growth prospects. Martek sells on an October 2009 consensus P/E of 15.1. This falls to 13.1 on a consensus forecast for October 2010. However, the forecast for 2010 earnings per share vary enormously, with the highest being $1.80 and the lowest $1.28 and consensus of $1.40.
Therefore, we believe the shares are attractive given the revenue growth potential in its adult market products, strong cash flow, improving demographics, and the company’s stated goal of improving gross margins. We feel that the company should earn between $1.40 and $1.50 per share for the year ending October 2010.
The company is expected to report fourth 2009 quarter earnings between Dec. 11-16. Consensus estimates call for earnings per share of $0.33.
click to enlarge
Anyone know the PE ratios for Algea companies ?
Someone confirm 640M BEHL shares outstanding ?
sl62. Thanks for your list of all the irons in the fire.
25 million doesn't look far fetched for 2010.
ENTK alone with 17 x 10acre farms would account for half of that.
Were in the right place at the right time.
1 dollar is within the realm of possibility when you consider our leading edge in a disruptive technology that the world is embracing. I think I'll bump mine up to match you. Good call.